Remove FDA Remove Licensing Remove Presentation
article thumbnail

FDA Outlines Considerations for Conducting Clinical Investigations Using Psychedelic Drugs

Hall Render

In June 2023, the Food and Drug Administration (“FDA”) released Draft Guidance outlining its current view of the psychedelic research landscape. While the FDA does not define psychedelics, it indicated that the shorthand term “psychedelic” includes “classic psychedelics,” which are typically understood to be 5-HT2 agonists (e.g.,

FDA 40
article thumbnail

We Look Forward to Seeing You at the Foley & Lardner Digital Health Legal Session and Reception in Tel Aviv

Healthcare Law Today

market presents a tremendous opportunity for Israel-based health care companies, though the complexities and challenges of U.S. FDA Regulatory Considerations for the U.S. ” The U.S. health care delivery systems. law must be thoroughly understood. We will have a networking reception immediately following the program.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Health in the Metaverse: Three Legal Considerations

Healthcare Law Blog

These advancements, present challenges and raise novel questions as to how the current healthcare and life sciences legal regime would apply to the metaverse. In response to the growth of the metaverse and digital health generally, the FDA has been working to expand its guidance in the area. Data Privacy and Security. 1, 2021). [2]

FDA 90
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

Together, these articles underscore the injustice of the present moment and emphasize the need to reform intellectual property protections for government-funded inventions of public health significance. Recent Research on Public Funding of mRNA Technology The first of the two new articles is an in-depth empirical study of U.S.

article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

This precautionary measure adopted by the agency aims to ensure the health and physical integrity of the Brazilian population since, to date, no studies have been presented to ANVISA that prove the effectiveness and safety of the phenol product for use in such procedures. Some peptides can be produced for use in medications.

FDA 52
article thumbnail

Key Legal Issues Facing Telehealth Platforms, as Compliance Concerns Bubble for Platforms Launched During the Public Health Emergency

Health Care Law Brief

For example, New York continues to maintain a professional licensing waiver that enables certain providers, licensed out of state, to render care within the state, for the duration of the declared state of emergency. Variety of Risks Present in Telehealth Arrangements. Provider Licenses.

article thumbnail

How Should RPM Vendors Choose Remote Patient Monitoring Device Suppliers?

Healthcare IT Today

They purchase the technical solutions such as algorithms and software licenses with no R&D or engineering capabilities on staff. RPM devices work as medical devices which are governed by the FDA and related departments. Principle 2: Evaluate the regulation competence of the suppliers. There were not any outside connections.

FDA 98